Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Maraganore John
Relationship:   Director
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   263,534    

Indirect Shares

   6,153,633      
Direct Value   $35,430,768    

Indirect Value

   $14,183,372      
Total Shares   6,417,167      
Total Value   $49,614,140      


Alnylam Pharmaceuticals Inc $33,990,086 Agios Pharmaceuticals Inc $1,435,338 Bluebird Bio, Inc. $5,343 Alnylam Pharmaceuticals Inc $33,990,086 Agios Pharmaceuticals Inc $1,435,338 Bluebird Bio, Inc. $5,343
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Alnylam Pharmaceuticals Inc ALNY Chief Executive Office... 2021-12-22 227,663 2021-12-22 3,133    Premium*  
            Regulus Therapeutics Inc. RGLS Director, 10% Owner 2012-10-10 0 2012-10-10 6,150,500    Premium*  
            Agios Pharmaceuticals Inc AGIO Director 2022-05-20 30,028 0    Premium*  
            Bluebird Bio, Inc. BLUE Director 2017-09-14 5,843 2014-07-14 0    Premium*  
* Premium Members only  

Records found :    154         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ALNY Alnylam Pharmaceuticals I... CEO   •       •      –    2011-12-12 4 AB $7.15 $9,995 D/D 1,397 51,788 0 -
ALNY Alnylam Pharmaceuticals I... CEO   •       •      –    2012-01-09 4 AB $8.81 $9,995 D/D 1,134 52,922 0 -
ALNY Alnylam Pharmaceuticals I... CEO   •       •      –    2012-02-21 4 B $10.75 $59,996 D/D 5,581 58,503 2.81 -
ALNY Alnylam Pharmaceuticals I... CEO   •       •      –    2012-12-19 4 OE $0.48 $8,843 D/D 18,617 77,120 0 -
ALNY Alnylam Pharmaceuticals I... CEO   •       •      –    2014-02-03 4 OE $6.78 $314,124 D/D 46,331 77,613 0 -
ALNY Alnylam Pharmaceuticals I... CEO   •       •      –    2014-04-14 4 OE $9.14 $524,962 D/D 28,707 106,320 0 -
ALNY Alnylam Pharmaceuticals I... CEO   •       •      –    2016-07-19 4 OE $22.75 $342,979 D/D 15,076 148,465 0 -
ALNY Alnylam Pharmaceuticals I... CEO   •       •      –    2016-07-19 4 AS $63.73 $961,998 D/D (15,076) 133,389 0 -
ALNY Alnylam Pharmaceuticals I... CEO   •       •      –    2016-07-20 4 AS $64.29 $988,592 D/D (15,075) 133,389 0 -
ALNY Alnylam Pharmaceuticals I... CEO   •       •      –    2016-07-20 4 OE $22.75 $342,956 D/D 15,075 148,464 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2013-02-27 4 AS $23.47 $704,019 D/D (30,000) 47,120 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2013-02-28 4 AS $23.50 $669,900 D/D (28,503) 18,617 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2013-07-10 4 AS $37.11 $2,226,822 D/D (60,000) 18,617 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2013-07-10 4 OE $0.95 $57,000 D/D 60,000 78,617 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2013-08-14 4 OE $0.95 $57,000 D/D 60,000 78,617 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2013-08-14 4 AS $48.77 $2,938,127 D/D (60,000) 18,617 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2013-09-11 4 AS $55.41 $3,271,524 D/D (58,947) 18,617 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2013-09-11 4 OE $0.95 $56,000 D/D 58,947 77,564 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2013-10-10 4 OE $6.78 $85,869 D/D 12,665 31,282 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2014-05-14 4 OE $6.78 $385,335 D/D 56,834 163,154 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2014-05-14 4 AS $57.20 $3,259,715 D/D (56,834) 106,320 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2014-05-15 4 AS $56.06 $3,188,227 D/D (56,834) 106,320 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2014-05-15 4 OE $6.78 $400,973 D/D 56,834 163,154 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2014-05-23 4 GD $0.00 $0 D/D 1,700 104,620 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2014-06-25 4 AS $65.86 $3,757,171 D/D (56,834) 106,320 0 -
  154  Records found
  1   2  3   4   5   6   7      
  Page 2 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us